Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity

被引:41
|
作者
Midgley, A. [1 ]
Beresford, M. W. [1 ,2 ]
机构
[1] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L12 2AP, Merseyside, England
[2] Alder Hey Childrens NHS Fdn Trust, Dept Paediat Rheumatol, Liverpool, Merseyside, England
关键词
Neutrophil sub population; low density granulocytes; !text type='JS']JS[!/text]LE; NEUTROPHILS;
D O I
10.1177/0961203315608959
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neutrophils are implicated in a wide range of non-infectious inflammatory conditions. A subset of neutrophils in the peripheral circulation of systemic lupus erythematosus (SLE) patients has been described and termed low density granulocytes (LDGs). This study investigates the expression of LDG in juvenile-onset SLE (JSLE) patients compared to controls, and any correlations with disease activity. Neutrophils and LDGs were isolated from JSLE (n = 13) and paediatric non-inflammatory control patients (n = 12). Cell populations were assessed and compared using flow cytometry and morphological analysis. Standard clinical data, which included disease activity markers/scores, were collected for each patient. Significantly increased LDG expression (% mean +/- SEM, range) was observed in JSLE patients (10.4 +/- 3.26, 3.41-36.3) compared to controls (2.4 +/- 0.44, 0.36-5.27; p = 0.005). A statistically significant positive correlation was observed between LDG expression and the British Isles Lupus Activity Group (correlation coefficient 0.685; p = 0.010) and SLE Disease Activity Index (correlation coefficient 0.567; p = 0.043) and the biomarker of dsDNA-antibodies (correlation coefficient 0.590; p = 0.043). Here we observe increased expression in LDGs in JSLE patients, which correlate with dsDNA antibody concentration and scores of disease activity. These correlations indicate that the increased LDG expression observed in this study may have a potential role in the pathogenesis of JSLE, and may be a useful biomarker. Lupus (2016) 25, 407-411.
引用
收藏
页码:407 / 411
页数:5
相关论文
共 50 条
  • [21] Rituximab therapy for juvenile-onset systemic lupus erythematosus
    Nwobi, Obioma
    Abitbol, Carolyn L.
    Chandar, Jayanthi
    Seeherunvong, Wacharee
    Zilleruelo, Gaston
    PEDIATRIC NEPHROLOGY, 2008, 23 (03) : 413 - 419
  • [22] Rituximab therapy for juvenile-onset systemic lupus erythematosus
    Obioma Nwobi
    Carolyn L. Abitbol
    Jayanthi Chandar
    Wacharee Seeherunvong
    Gastón Zilleruelo
    Pediatric Nephrology, 2008, 23 : 413 - 419
  • [23] Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus
    Abo-Shanab, Assem M.
    Kholoussi, Shams
    Kandil, Rania
    Dorgham, Dalia
    LUPUS, 2021, 30 (03) : 459 - 464
  • [24] Low bone mineral density is associated with low lean mass in Juvenile-onset systemic lupus erythematosus.
    Regio, Paula L.
    Bonfa, Eloisa
    Takayama, Liliam
    Pereira, Rosa M. R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S688 - S688
  • [25] Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus
    Mina, Rina
    Klein-Gitelman, Marisa S.
    Nelson, Shannen
    Eberhard, B. Anne
    Higgins, Gloria
    Singer, Nora G.
    Onel, Karen
    Tucker, Lori
    O'Neil, Kathleen M.
    Punaro, Marilynn
    Levy, Deborah M.
    Haines, Kathleen
    Martini, Alberto
    Ruperto, Nicolino
    Lovell, Daniel
    Brunner, Hermine I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (02) : 401 - 406
  • [26] Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus
    Nur Canpolat
    Ozgur Kasapcopur
    Salim Caliskan
    Selman Gokalp
    Meltem Bor
    Mehmet Tasdemir
    Lale Sever
    Nil Arisoy
    Pediatric Nephrology, 2013, 28 : 305 - 313
  • [27] Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus
    Canpolat, Nur
    Kasapcopur, Ozgur
    Caliskan, Salim
    Gokalp, Selman
    Bor, Meltem
    Tasdemir, Mehmet
    Sever, Lale
    Arisoy, Nil
    PEDIATRIC NEPHROLOGY, 2013, 28 (02) : 305 - 313
  • [28] Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus
    Liphaus, Bernadete L.
    Kiss, Maria Helena B.
    Carrasco, Solange
    Palmeira, Patricia
    Goldenstein-Schainberg, Claudia
    Carneiro-Sampaio, Magda
    CLINICAL RHEUMATOLOGY, 2017, 36 (12) : 2847 - 2852
  • [29] Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus
    Bernadete L. Liphaus
    Maria Helena B. Kiss
    Solange Carrasco
    Patrícia Palmeira
    Claudia Goldenstein-Schainberg
    Magda Carneiro-Sampaio
    Clinical Rheumatology, 2017, 36 : 2847 - 2852
  • [30] Accrual Damage Assessment In Juvenile-Onset Systemic Lupus Erythematosus
    Ovalles, Juan G.
    Martinez-Barrio, Julia
    Lopez-Longo, Francisco J.
    de la Torre, Inmaculada
    Martinez-Estupinan, Lina
    Nieto, Juan C.
    Carreno, Luis
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S794 - S794